Advances in Medical Science: Collaboration for Growth -29/02/2012,

The NHS is the UK's largest customer of medicines and medical technologies. In addition to delivering high-quality healthcare, it has a great role to play in strengthening the country's economy, contributing directly to the success of Britain's thriving life sciences sector. Close working between the NHS and industry  including devices, diagnostics, pharma and biotech companies  and some of the leading universities and research centres in the world, supports the ability of the UK to deliver health benefits to the public, patients and society.

Speakers :

• Professor Sir John Tooke - President,Academy of Medical Sciences
• George Freeman MP - Government life sciences adviser and Member of Parliament for Mid Norfolk Department of Health, A strategic approach to innovation in the reformed NHS
• Professor Robert Lechler - Executive Director, King's Health Partners
• Richard Stubbs - Implementation Lead, NHS Global
• Alasdair Gaw - Lead Specialist, Stratified Medicine,Technology Strategy Board

Topics to be discussed :

Planning for growth

• A strategic approach to innovation in the reformed NHS
• Collaboration for success
• Simplifying health research regulation
• Improving the procurement of innovation
• Going global promoting UK healthcare innovation.

Following the launch of the Life Sciences Strategy and the Innovation Health and Wealth report, Advances in Medical Science: Collaboration for Growth will be a showcase of the latest developments in medical science, offering an ideal opportunity for the science community, the NHS and their respective partners to come together to discuss innovative medicines and treatments for pressing health issues.

View Full Programme and book online here .